Atara Biotherapeutics, Inc. 4 filing

Filed 2026-07-24 · Report date 2026-07-22 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001104659-26-086733
Form type: 4
CIK: 0001604464
Primary document: https://www.sec.gov/Archives/edgar/data/1604464/000110465926086733/xslF345X06/tm2621190-2_4seq1.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Atara Biotherapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change